Siglec15 blocking mAbs significantly inhibited tumor growth in mice inoculated with colon carcinoma cells mixed with wild-type bone marrow-derived macrophages (BMDMs) but not with Siglec15 knockout BMDMs (16). Here, SIGLEC15 is linked to colon carcinoma.